Medtronic plc
MDT
Kedudukan dalam Saham
#183
Medtronic plc is a leading global medical technology enterprise that invents,... Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.
Harga Saham
$94.22
Modal Pasaran
$120.52B
Perubahan (1 hari)
1.36%
Perubahan (1 tahun)
-1.78%
Negara
IE
Perdagangan Medtronic plc (MDT)
Kategori
Healthcare
Nisbah P/E bagi Medtronic plc (MDT)
Nisbah P/E pada May 2026 TTM: 21.39
Menurut laporan kewangan dan harga saham terkini Medtronic plc, nisbah P/E semasa (TTM) ialah 21.39. Pada akhir 2024, syarikat mempunyai nisbah P/E sebanyak 28.98.
Sejarah nisbah P/E bagi Medtronic plc dari 2000 hingga 2026
Nisbah P/E pada akhir setiap tahun
| Tahun | Nisbah P/E | Ubah |
|---|---|---|
| 2026 (TTM) | 21.39 | -8.48% |
| 2025 | 23.37 | -19.35% |
| 2024 | 28.98 | -9.95% |
| 2023 | 32.18 | 15.76% |
| 2022 | 27.80 | -43.06% |
| 2021 | 48.83 | 75.64% |
| 2020 | 27.80 | 9.46% |
| 2019 | 25.40 | -28.52% |
| 2018 | 35.53 | 24.91% |
| 2017 | 28.44 | -9.80% |
| 2016 | 31.53 | -0.78% |
| 2015 | 31.78 | 65.27% |
| 2014 | 19.23 | 40.13% |
| 2013 | 13.72 | 23.30% |
| 2012 | 11.13 | -23.39% |
| 2011 | 14.53 | -6.85% |
| 2010 | 15.60 | -5.77% |
| 2009 | 16.55 | -32.91% |
| 2008 | 24.67 | 13.60% |
| 2007 | 21.72 | -8.07% |
| 2006 | 23.62 | -33.21% |
| 2005 | 35.37 | 13.16% |
| 2004 | 31.26 | -13.97% |
| 2003 | 36.33 | -33.97% |
| 2002 | 55.03 | 7.28% |
| 2001 | 51.29 | -9.73% |
| 2000 | 56.83 | 0.00% |
Nisbah P/E untuk syarikat serupa atau pesaing
| Syarikat | Nisbah P/E | Perbezaan Nisbah P/E | Negara |
|---|---|---|---|
| 33.11 | 54.80% |
US
|
|
| 28.94 | 35.33% |
US
|
|
| 17.34 | -18.93% |
US
|
|
| - | - |
DE
|
|
| 49.68 | 132.30% |
US
|
Cara membaca nisbah P/E
Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.
Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.
Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.